- Home
- Publications
- Publication Search
- Publication Details
Title
Therapies to Slow, Stop, or Reverse Parkinson’s Disease
Authors
Keywords
-
Journal
Journal of Parkinsons Disease
Volume 8, Issue s1, Pages S115-S121
Publisher
IOS Press
Online
2018-12-19
DOI
10.3233/jpd-181481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LRRK2 is a negative regulator of Mycobacterium tuberculosis phagosome maturation in macrophages
- (2018) Anetta Härtlova et al. EMBO JOURNAL
- The role of glucocerebrosidase in Parkinson disease pathogenesis
- (2018) Matthew E. Gegg et al. FEBS Journal
- Brain inflammatory cascade controlled by gut-derived molecules
- (2018) Hartmut Wekerle NATURE
- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
- (2018) Seung Pil Yun et al. NATURE MEDICINE
- Graphene quantum dots prevent α-synucleinopathy in Parkinson’s disease
- (2018) Donghoon Kim et al. Nature Nanotechnology
- Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
- (2018) Eugenio Mercuri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Functional variants in the LRRK2 gene confer shared effects on risk for Crohn’s disease and Parkinson’s disease
- (2018) Ken Y. Hui et al. Science Translational Medicine
- Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease
- (2018) Margaret Schenkman et al. JAMA Neurology
- Effects of ambroxol on the autophagy-lysosome pathway and mitochondria in primary cortical neurons
- (2018) J. Magalhaes et al. Scientific Reports
- Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection
- (2017) Viviane Labrie et al. Journal of Innate Immunity
- Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
- (2017) Dilan Athauda et al. LANCET
- New perspectives on study designs for evaluating neuroprotection in Parkinson's disease
- (2017) Laetitia Thibault et al. MOVEMENT DISORDERS
- T cells from patients with Parkinson’s disease recognize α-synuclein peptides
- (2017) David Sulzer et al. NATURE
- Parkinson disease: Defining PD subtypes — a step toward personalized management?
- (2017) Caroline H. Williams-Gray et al. Nature Reviews Neurology
- β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease
- (2017) Shuchi Mittal et al. SCIENCE
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
- (2016) Timothy R. Sampson et al. CELL
- Chronic, intermittent convection-enhanced delivery devices
- (2016) Owen Lewis et al. JOURNAL OF NEUROSCIENCE METHODS
- Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study
- (2016) Per Svenningsson et al. MOVEMENT DISORDERS
- Insulin resistance and Parkinson’s disease: A new target for disease modification?
- (2016) D. Athauda et al. PROGRESS IN NEUROBIOLOGY
- Safety and tolerability of BAN2401 - a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody
- (2016) Veronika Logovinsky et al. Alzheimers Research & Therapy
- A Missense LRRK2 Variant Is a Risk Factor for Excessive Inflammatory Responses in Leprosy
- (2016) Vinicius M. Fava et al. PLoS Neglected Tropical Diseases
- UDCA exerts beneficial effect on mitochondrial dysfunction inLRRK2G2019Scarriers and in vivo
- (2015) Heather Mortiboys et al. NEUROLOGY
- Effect of selective LRRK2 kinase inhibition on nonhuman primate lung
- (2015) Reina N. Fuji et al. Science Translational Medicine
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
- (2014) Franziska Richter et al. Neurotherapeutics
- The c-Abl inhibitor, Nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease
- (2014) Senthilkumar S. Karuppagounder et al. Scientific Reports
- Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease
- (2013) Heather Mortiboys et al. BRAIN
- Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease
- (2013) Jeffrey H. Kordower et al. BRAIN
- Exenatide and the treatment of patients with Parkinson’s disease
- (2013) Iciar Aviles-Olmos et al. JOURNAL OF CLINICAL INVESTIGATION
- Fine-Mapping, Gene Expression and Splicing Analysis of the Disease Associated LRRK2 Locus
- (2013) Daniah Trabzuni et al. PLoS One
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- A comparative study of Lrrk2 function in primary neuronal cultures
- (2010) Justus C. Dächsel et al. PARKINSONISM & RELATED DISORDERS
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search